UPU-17387-53386
5 vaccinations
2 coded responses
24 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 337 / FL
- Registered
- 2021-03-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
LM3-29304-50662
Child or adolescent in my care · Female · 2022-06-28
EBG-29628-97065
Child or adolescent in my care · Male · 2022-06-28
W3Q-26184-97922
Child or adolescent in my care · Female · 2022-06-28
U8X-26698-88681
Child or adolescent in my care · Female · 2023-03-22
Timeline
-
2020-12-28
Dose 1 — Pfizer-BioNTech
-
2021-01-19
Dose 2 — Pfizer-BioNTech
-
2021-03-24
Registered in v-safe
- 2021-04-20
- 2021-07-20
-
2021-09-29
Dose 3 — Pfizer-BioNTech
-
2021-10-01
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Muscle or body aches, DiarrheaAdult check-in
-
2021-10-02
Survey response — days 1–6 daily, dose 3MedDRA: Axillary pain — Feeling: GoodFree text: Axillary discomfort (?lymphatic)MedDRA releases: 2024-11 · check-in free text available
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-06
- 2021-10-13
- 2021-10-20
- 2021-10-27
- 2021-11-03
- 2021-11-11
-
2021-12-29
Survey response — 3 months, dose 3MedDRA: Nasopharyngitis — Feeling: FairFree text: ColdMedDRA releases: 2024-11 · check-in free text available
- 2022-03-30
-
2022-06-17
Dose 4 — Moderna
- 2022-06-28
- 2022-07-01
- 2022-07-08
- 2022-07-15
- 2022-07-22
- 2022-07-29
- 2022-09-16
-
2022-10-16
Dose 5 — Moderna
- 2022-12-16
- 2023-04-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-28 | Pfizer-BioNTech | |
| 2 | 2021-01-19 | Pfizer-BioNTech | |
| 3 | 2021-09-29 | Pfizer-BioNTech | No |
| 4 | 2022-06-17 | Moderna | No |
| 5 | 2022-10-16 | Moderna | No |
Free text
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Axillary discomfort (?lymphatic)
Release 10 — 3 months, dose 3
Symptoms: Cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SRO | Axillary pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release